Boehringer Ingelheim (Taiwan)

Boehringer Ingelheim (Taiwan)

C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Boehringer Ingelheim (Taiwan), Taiwan, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

52%


Total
Publications

201


Total Open
Publications

104


Total
Citations

23K


Open Access
Percentage

52%


Total
Publications

201


Total Open
Publications

104


Total
Citations

23K

Wikipedia

Website

download

Breakdown

31% 17% 2% 50%

Publisher Open

31%

Both

17%

Other Platform Open

2%

Closed

50%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416182022Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

36%OA Journal

OA Journal 36%

34

Hybrid 33%

31

No Guarantees 31%

29

Other Platform Open

Domain 61%

23

Institution 42%

16

Other Internet 16%

6

Public 8%

3

Preprint 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
23
DOI
Other Internet
5
Figshare
Public
3
Europe PMC
Domain
3
Imperial College London - Spiral
Institution
2
DANS - Data Archiving and Networked Services
Institution
2
Yonsei University Medical Library - YUHSpace
Institution
1
Würzburg University - Online Publication Service of Würzburg University
Institution
1
Unknown Repository
Other Internet
1
Université Libre de Bruxelles - Dépôt institutionnel de l'Université libre de Bruxelles
Institution
1
1 / 3

Data updated 18 August 2025

Share

Share

Share